[Smoking and coronavirus disease 2019 (COVID-19)].
作者信息
Underner M, Peiffer G, Perriot J, Jaafari N
机构信息
Unité de recherche clinique, centre hospitalier Henri-Laborit, université de Poitiers, 370, avenue Jacques-Cœur, CS 10587, 86021 Poitiers cedex, France.
Service de pneumologie, CHR de Metz-Thionville, 57038 Metz, France.
出版信息
Rev Mal Respir. 2020 May;37(5):433-436. doi: 10.1016/j.rmr.2020.04.001. Epub 2020 Apr 8.
Abstract
摘要
相似文献
1
[Smoking and coronavirus disease 2019 (COVID-19)].[吸烟与2019冠状病毒病（COVID-19）]
Rev Mal Respir. 2020 May;37(5):433-436. doi: 10.1016/j.rmr.2020.04.001. Epub 2020 Apr 8.
2
Is COVID-19 more severe in older men?新冠病毒肺炎在老年男性中病情更严重吗？
Postgrad Med J. 2020 Jul;96(1137):426. doi: 10.1136/postgradmedj-2020-137867. Epub 2020 May 13.
3
Can estrogens protect against COVID-19? The COVID-19 puzzling and gender medicine.雌激素能预防新型冠状病毒肺炎吗？新型冠状病毒肺炎之谜与性别医学。
Minerva Ginecol. 2020 Jun;72(3):178-179. doi: 10.23736/S0026-4784.20.04594-3.
4
Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus.腹泻可能被低估了：2019新型冠状病毒中的一个缺失环节。
Gut. 2020 Jun;69(6):1141-1143. doi: 10.1136/gutjnl-2020-320832. Epub 2020 Feb 26.
5
Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis.失代偿期肝硬化患者COVID-19死亡率增加的潜在机制。
Hepatol Int. 2020 Sep;14(5):884-885. doi: 10.1007/s12072-020-10084-4. Epub 2020 Sep 4.
6
Why are women better protected from COVID-19: Clues for men? Sex and COVID-19.为何女性在新冠病毒肺炎中受到更好的保护：对男性的启示？性别与新冠病毒肺炎。
Int J Cardiol. 2020 Sep 15;315:105-106. doi: 10.1016/j.ijcard.2020.05.026. Epub 2020 May 11.
7
COVID-19 and the pulmonary vascular injury.新型冠状病毒肺炎与肺血管损伤
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972276. doi: 10.1177/1470320320972276.
8
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度：一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
9
Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumonia.重症新型冠状病毒肺炎患者窦性心动过缓的临床分析
Crit Care. 2020 May 26;24(1):257. doi: 10.1186/s13054-020-02933-3.
10
Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.血管紧张素转换酶2（ACE2）受体、哮喘与严重新型冠状病毒肺炎感染风险
Eur Ann Allergy Clin Immunol. 2020 Nov;52(6):282-285. doi: 10.23822/EurAnnACI.1764-1489.169. Epub 2020 Nov 3.
引用本文的文献
1
Global data analysis and risk factors associated with morbidity and mortality of COVID-19.新型冠状病毒肺炎发病和死亡相关的全球数据分析及风险因素
Gene Rep. 2022 Mar;26:101505. doi: 10.1016/j.genrep.2022.101505. Epub 2022 Jan 15.
2
COVID-19 and Smoking: What Evidence Needs Our Attention?新冠病毒与吸烟：哪些证据需要我们关注？
Front Physiol. 2021 Mar 18;12:603850. doi: 10.3389/fphys.2021.603850. eCollection 2021.
3
[Covid-19 and smoking].[新冠病毒与吸烟]
Arch Mal Coeur Vaiss Pratique. 2021 Jan;2021(294):26-29. doi: 10.1016/j.amcp.2020.11.006. Epub 2020 Dec 2.
4
Tobacco use as a well-recognized cause of severe COVID-19 manifestations.吸烟是导致严重 COVID-19 症状的一个公认原因。
Respir Med. 2021 Jan;176:106233. doi: 10.1016/j.rmed.2020.106233. Epub 2020 Nov 19.
5
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review.新冠疫情时代的成瘾问题：当前证据、未来展望——全面综述。
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110070. doi: 10.1016/j.pnpbp.2020.110070. Epub 2020 Aug 12.
本文引用的文献
1
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.2019 年冠状病毒病患者中某些基础健康状况的初步估计——美国，2020 年 2 月 12 日至 3 月 28 日。
MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):382-386. doi: 10.15585/mmwr.mm6913e2.
2
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2.预测血管紧张素转化酶 2（ACE2）作为 SARS-CoV-2 受体的利用能力。
Microbes Infect. 2020 May-Jun;22(4-5):221-225. doi: 10.1016/j.micinf.2020.03.003. Epub 2020 Mar 19.
3
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
4
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.分析与 2019 年新型冠状病毒病住院患者疾病结局相关的因素。
Chin Med J (Engl). 2020 May 5;133(9):1032-1038. doi: 10.1097/CM9.0000000000000775.
5
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
6
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
7
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
8
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.新型冠状病毒受体识别：基于 SARS 冠状病毒长达十年结构研究的分析。
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.00127-20.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
Tobacco and the lung cancer epidemic in China.烟草与中国的肺癌流行
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S21-S30. doi: 10.21037/tlcr.2019.03.12.
Zotero 插件